Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US8404217B2 · kind B2 · utility
1Cited by
461References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 2005 |
| Grant date | Mar 26, 2013 |
| Priority date | — |
| Expiry date | Oct 12, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/1617
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Formulations are provided for pulmonary administration of an antifungal agent to a patient. Methods of using the formulations in the treatment of antifungal infections are also provided, including treatment of pulmonary aspergillosis with amphotericin B-containing formulations. Methods of manufacturing the formulations to achieve optimum properties are provided as well.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.